https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate resources.
Management believes this provides
comparability of the performance of the combined businesses.
Management excludes intangible asset amortization from adjusted EPS as it believes excluding acquired intangible asset
amortization is a useful measure of current period earnings per share.
https://www.avient.com/news/avient-announces-new-eco-conscious-flexible-option-liquid-metering
The ColorMatrix FlexOne system incorporates efficiency-enhancing features including an integrated pump with a gravimetric liquid metering system along with an automated and self-correcting calibration capability.
https://www.avient.com/news/avient-develops-new-dairy-packaging-additive-technology-meet-tio2-restrictions
Complete with food contact approvals for the European Union and FDA, this new Lactra additive is compatible with the PET recycle stream for fibers, sheet, and strapping.
https://www.avient.com/news/oncap-aversive-masterbatch-additives-polyone-receive-biocidal-product-regulation-authorization-europe
OnCap Aversive uses only low-concern biocidal chemicals officially authorized by the European Union, leaving cable manufacturers with no doubts about EU compliance.
https://www.avient.com/idea/medical-device-shielded-radiation-without-lead
The European Union’s Restriction of Hazardous Substances (RoHS) eventually would lead to a ban on lead shielding components in equipment like the company’s new line of computed tomography (CT) scanners.
https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions?ind[]=6598
Even regulations such as the updated European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR) that are only valid for products sold in Europe, should preferably be considered from the start to ensure access to the European market.
https://www.avient.com/knowledge-base/article/securing-supplies-medical-plastic-solutions?pname[]=17815
Even regulations such as the updated European Union Medical Device Regulation (EU MDR) and In Vitro Diagnostic Regulation (IVDR) that are only valid for products sold in Europe, should preferably be considered from the start to ensure access to the European market.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
OUR STRATEGY
Specialization
Differentiates us through unique value-creating offerings to our customers.
Globalization
Positions us to serve our customers consistently, everywhere in the world.
It’s why customers choose us.
https://www.avient.com/sites/default/files/2021-02/avient-ir-presentation-goldman-sachs-and-morgan-stanley.pdf
OUR STRATEGY
Specialization
Differentiates us through unique value-creating offerings to our customers.
Globalization
Positions us to serve our customers consistently, everywhere in the world.
It’s why customers choose us.
https://www.avient.com/sites/default/files/2022-09/Cesa Aversive Product Bulletin.pdf
Only authorized masterbatches for the purpose
of conferring a biocidal property to an article can
be used inside the European Union.
Reference Product Name Carrier
CC10087477BG 87477 EVA Anti-Rat Masterbatch EVA
CC10107079BG 107079 EVA Anti-Termite Masterbatch EVA
CC10125842BG 5842 EVA Multi-Repel Masterbatch EVA
VALUE SOLUTION
The European Union adopted Guidelines in 2015
establishing that masterbatches with biocidal
function needed to be authorized for use in
European Union.1 As such, masterbatch products
containing aversive or repellent substances are
considered as a biocidal product.2 Indeed, deterring
harmful organisms is a biocidal function.